Papaverine Hydrochloride
- C20H21NO4.ClH
- C20H22ClNO4
- PAPAVERINE HYDROCHLORIDE
- 61-25-6
- Cardoverina
- Artegodan
- Cardiospan
- Create:2005-03-27
- Modify:2025-02-01
- Cerespan
- Hydrochloride, Papaverine
- Papaverine
- Papaverine Hydrochloride
- Pavabid
- Pavatym
- PAPAVERINE HYDROCHLORIDE
- 61-25-6
- Cardoverina
- Artegodan
- Cardiospan
- Papaversan
- Delapav
- Dilaves
- Dispamil
- Drapavel
- Durapav
- Dynovas
- Forpavin
- Pameion
- Papacon
- Papalease
- Pavacen
- Pavatest
- Paverolan
- Paveron
- Pavnell
- Alapav
- Myobid
- Vasal
- Papaverine Hcl
- Pavabid
- Ro-Papav
- Vaso-Pav
- Cepaverin
- Pavagrant
- Therapav
- Cerebid
- Optenyl
- Pavacap
- Pavakey
- Pavased
- Dipav
- Lapav
- Papaverinium chloride
- Papanerin-hcl
- 1-(3,4-Dimethoxybenzyl)-6,7-dimethoxyisoquinoline hydrochloride
- Spasmo-Nit
- Papavarine chlorhydrate
- Pap-Kaps-150
- Papaverine chlorohydrate
- PAP H
- Cerespan
- vasorin
- Papaverine monohydrochloride
- Chlorhydrate de papaverine
- Papaverine (hydrochloride)
- NCI-C56359
- CCRIS 3804
- 6,7-Dimethoxy-1-veratrylisoquinoline hydrochloride
- Papaverine, HCl
- EINECS 200-502-1
- NSC 35443
- NSC-35443
- UNII-23473EC6BQ
- DTXSID9025825
- 23473EC6BQ
- Papaverini hydrochloridum
- Isoquinoline, 6,7-dimethoxy-1-veratryl-, hydrochloride
- MLS000028497
- DTXCID705825
- Papaverine.HCl
- 6,7,3',4'-Tetramethoxy-1-benzylisoquinoline hydrochloride
- Papaverine hydrochloride [USP:JAN]
- Isoquinoline, 1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-, hydrochloride
- MFCD00012745
- SMR000058283
- NSC35443
- Papanerin-HCl [German]
- Papaverine hydrochloride (USP:JAN)
- PAPAVERINE HYDROCHLORIDE (MART.)
- PAPAVERINE HYDROCHLORIDE [MART.]
- PAPAVERINE HYDROCHLORIDE (USP-RS)
- PAPAVERINE HYDROCHLORIDE [USP-RS]
- PAPAVERINE HYDROCHLORIDE (EP MONOGRAPH)
- PAPAVERINE HYDROCHLORIDE (USP MONOGRAPH)
- PAPAVERINE HYDROCHLORIDE [EP MONOGRAPH]
- PAPAVERINE HYDROCHLORIDE [USP MONOGRAPH]
- CAS-61-25-6
- SR-01000003098
- Chlorhydrate de papaverine [French]
- NCGC00015810-02
- Pamelon
- Papaverine hydrochloride [JAN]
- Qua bid
- Prestwick_376
- Pavabid (TN)
- component of Copavin
- Papavarine hydrochloride
- Papaverine, hydrochloride
- Hydrochloride, Papaverine
- Opera_ID_1617
- REGID_for_CID_6084
- MLS001148655
- MLS002222208
- PAPAVERINE CHLORHYDRATE
- CHEMBL98123
- SCHEMBL121268
- SPECTRUM1500459
- Papaverine hydrochloride, powder
- HMS1569F08
- HMS1920F06
- Pharmakon1600-01500459
- Tox21_110226
- Tox21_500957
- CCG-40065
- HY-18077A
- NSC757256
- PAPAVERINE HYDROCHLORIDE [MI]
- Papaverine hydrochloride (JP18/USP)
- AKOS005111070
- Tox21_110226_1
- CS-5015
- LP00957
- NSC-757256
- PAPAVERINE HYDROCHLORIDE [HSDB]
- PAPAVERINE HYDROCHLORIDE [VANDF]
- NCGC00015810-12
- NCGC00094258-01
- NCGC00094258-02
- NCGC00094258-03
- NCGC00094258-04
- NCGC00094258-05
- NCGC00094258-06
- NCGC00261642-01
- PAPAVERINE HYDROCHLORIDE [WHO-DD]
- PAPAVERINE HYDROCHLORIDE [WHO-IP]
- AS-13262
- 1-(3,7-dimethoxyisoquinoline hydrochloride
- DB-053821
- EU-0100957
- NS00078975
- P0016
- 6,7-DIMETHOXY-1-VERATRYL HYDROCHLORIDE
- D02218
- D86684
- P 3510
- PAPAVERINI HYDROCHLORIDUM [WHO-IP LATIN]
- Isoquinoline,7-dimethoxy-1-veratryl-, hydrochloride
- Papaverine.HCl, 1mg/ml in Methanol (as free base)
- SR-01000003098-2
- SR-01000003098-4
- SR-01000003098-9
- WLN: T66 CNJ B1R CO1 DO1& HO1 IO1 &GH
- Q27253713
- SR-01000003098-11
- 6,3',4'-Tetramethoxy-1-benzylisoquinoline hydrochloride
- 6,7-Dimethoxy-1-(3,4-dimethoxybenzyl)isoquinoline monohydrochloride
- Isoquinoline,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-, hydrochloride
- Papaverine hydrochloride, British Pharmacopoeia (BP) Reference Standard
- Papaverine hydrochloride, European Pharmacopoeia (EP) Reference Standard
- 1-((3,4-DIMETHOXYPHENYL)METHYL)-6,7-DIMETHOXYISOQUINOLINE HYDROCHLORIDE
- Isoquinoline, 1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-, hydrochloride (1:1)
- Papaverine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
- Papaverine hydrochloride, United States Pharmacopeia (USP) Reference Standard
H301 (47%): Toxic if swallowed [Danger Acute toxicity, oral]
H302 (53%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P316, P301+P317, P321, P330, P405, and P501
(The corresponding statement to each P-code can be found at the GHS Classification page.)
Aggregated GHS information provided per 132 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.
Acute Tox. 3 (47%)
Acute Tox. 4 (53%)
EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.
SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.
INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used; if not available, use a level of protection greater than or equal to that advised under Protective Clothing.
INGESTION: DO NOT INDUCE VOMITING. If the victim is conscious and not convulsing, give 1 or 2 glasses of water to dilute the chemical and IMMEDIATELY call a hospital or poison control center. Be prepared to transport the victim to a hospital if advised by a physician. If the victim is convulsing or unconscious, do not give anything by mouth, ensure that the victim's airway is open and lay the victim on his/her side with the head lower than the body. DO NOT INDUCE VOMITING. IMMEDIATELY transport the victim to a hospital. (NTP, 1992)
Excerpt from ERG Guide 154 [Substances - Toxic and/or Corrosive (Non-Combustible)]:
IMMEDIATE PRECAUTIONARY MEASURE: Isolate spill or leak area in all directions for at least 50 meters (150 feet) for liquids and at least 25 meters (75 feet) for solids.
SPILL: Increase the immediate precautionary measure distance, in the downwind direction, as necessary.
FIRE: If tank, rail tank car or highway tank is involved in a fire, ISOLATE for 800 meters (1/2 mile) in all directions; also, consider initial evacuation for 800 meters (1/2 mile) in all directions. (ERG, 2024)
SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a strong soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.
STORAGE PRECAUTIONS: You should store this material in a refrigerator. Protect from light. (NTP, 1992)
Ethers
Hydrocarbons, Aromatic
Salts, Acidic
IMAP assessments - Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-, hydrochloride: Environment tier I assessment
IMAP assessments - Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-, hydrochloride: Human health tier I assessment
Patents are available for this chemical structure:
https://patentscope.wipo.int/search/en/result.jsf?inchikey=UOTMYNBWXDUBNX-UHFFFAOYSA-N
- Australian Industrial Chemicals Introduction Scheme (AICIS)Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-, hydrochloridehttps://services.industrialchemicals.gov.au/search-assessments/
- CAMEO ChemicalsLICENSECAMEO Chemicals and all other CAMEO products are available at no charge to those organizations and individuals (recipients) responsible for the safe handling of chemicals. However, some of the chemical data itself is subject to the copyright restrictions of the companies or organizations that provided the data.https://cameochemicals.noaa.gov/help/reference/terms_and_conditions.htm?d_f=falsePAPAVERINE HYDROCHLORIDEhttps://cameochemicals.noaa.gov/chemical/20831CAMEO Chemical Reactivity Classificationhttps://cameochemicals.noaa.gov/browse/react
- CAS Common ChemistryLICENSEThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc/4.0/Papaverine hydrochloridehttps://commonchemistry.cas.org/detail?cas_rn=61-25-6
- ChemIDplusPapaverine hydrochloride [USP:JAN]https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000061256ChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- DTP/NCILICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuse
- EPA Chemicals under the TSCAIsoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-, hydrochloride (1:1)https://www.epa.gov/chemicals-under-tscaEPA TSCA Classificationhttps://www.epa.gov/tsca-inventory
- EPA DSSToxPapaverine hydrochloridehttps://comptox.epa.gov/dashboard/DTXSID9025825CompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-noticePapaverine hydrochloridehttps://echa.europa.eu/substance-information/-/substanceinfo/100.000.457Papaverine hydrochloride (EC: 200-502-1)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/70176
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingPAPAVERINE HYDROCHLORIDEhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/23473EC6BQ
- Open TargetsLICENSEDatasets generated by the Open Targets Platform are freely available for download.https://platform-docs.opentargets.org/licencePAPAVERINE HYDROCHLORIDEhttps://platform.opentargets.org/drug/CHEMBL98123
- CCSbaseCCSbase Classificationhttps://ccsbase.net/
- ChEMBLLICENSEAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).http://www.ebi.ac.uk/Information/termsofuse.htmlChEMBL Protein Target Treehttps://www.ebi.ac.uk/chembl/g/#browse/targets
- ClinicalTrials.govLICENSEThe ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use
- DailyMedPAPAVERINE HYDROCHLORIDEhttps://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=PAPAVERINE+HYDROCHLORIDE
- Drug Gene Interaction database (DGIdb)LICENSEThe data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.http://www.dgidb.org/downloadsPAPAVERINE HYDROCHLORIDEhttps://www.dgidb.org/drugs/rxcui:203132
- KEGGLICENSEAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial licensehttps://www.kegg.jp/kegg/legal.htmlTherapeutic category of drugs in Japanhttp://www.genome.jp/kegg-bin/get_htext?br08301.kegAnatomical Therapeutic Chemical (ATC) classificationhttp://www.genome.jp/kegg-bin/get_htext?br08303.kegTarget-based classification of drugshttp://www.genome.jp/kegg-bin/get_htext?br08310.kegDrugs listed in the Japanese Pharmacopoeiahttp://www.genome.jp/kegg-bin/get_htext?br08311.kegRisk category of Japanese OTC drugshttp://www.genome.jp/kegg-bin/get_htext?br08312.kegClassification of Japanese OTC drugshttp://www.genome.jp/kegg-bin/get_htext?br08313.keg
- Metabolomics WorkbenchPapaverine Hydrochloridehttps://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=143571
- National Drug Code (NDC) DirectoryLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingPAPAVERINE HYDROCHLORIDEhttps://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
- Natural Product Activity and Species Source (NPASS)Papaverine Hydrochloridehttps://bidd.group/NPASS/compound.php?compoundID=NPC133140
- NCI Thesaurus (NCIt)LICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseNCI Thesaurushttps://ncit.nci.nih.gov
- NLM RxNorm TerminologyLICENSEThe RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.htmlpapaverine hydrochloridehttps://rxnav.nlm.nih.gov/id/rxnorm/203132
- SpectraBasePapaverine HClhttps://spectrabase.com/spectrum/Bh49M36tUEQPapaverine HClhttps://spectrabase.com/spectrum/IfnZlwEJVXZ6,7-DIMETHOXY-1-VERATRYLISOQUINOLINE, HYDROCHLORIDEhttps://spectrabase.com/spectrum/5CfUjbVAkmT
- Springer Nature
- Wikidatapapaverine hydrochloridehttps://www.wikidata.org/wiki/Q27253713
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.htmlUrological Agentshttps://www.ncbi.nlm.nih.gov/mesh/68064804Phosphodiesterase Inhibitorshttps://www.ncbi.nlm.nih.gov/mesh/68010726Vasodilator Agentshttps://www.ncbi.nlm.nih.gov/mesh/68014665
- PubChem
- GHS Classification (UNECE)GHS Classification Treehttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html
- NORMAN Suspect List ExchangeLICENSEData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0https://creativecommons.org/licenses/by/4.0/NORMAN Suspect List Exchange Classificationhttps://www.norman-network.com/nds/SLE/
- EPA Substance Registry ServicesEPA SRS List Classificationhttps://sor.epa.gov/sor_internet/registry/substreg/LandingPage.do
- MolGenieMolGenie Organic Chemistry Ontologyhttps://github.com/MolGenie/ontology/
- PATENTSCOPE (WIPO)SID 403396476https://pubchem.ncbi.nlm.nih.gov/substance/403396476